Commentary

In this candidate-driven market, an employer's willingness to accommodate each person's unique situation puts them in a solid position.

The commercialization of cell and gene therapies raises several complex conversations and questions for employers and payers.

For advisors, the approaching deadline offers several opportunities to reengage plan sponsors and investment committees.

One of the most formidable challenges for businesses is balancing the needs of providing essential benefits against bottom-line expenditures.

Retirement plan fiduciaries, take note: Although TDFs are marketed as "set it and forget it," the Hughes decision suggests that you won't have this luxury.

You have clients who want to help. Here are 10 ways to tactfully get them thinking about specific situations.